Benefit of Ranbaxy deal to accrue in few years: Sun Pharma
It will take a "few years" for Sun Pharma to realise the benefits of its USD 4 billion takeover of Ranbaxy, said the company's Chairman Israel Makov.
Sep 29, 2014, 16:38 PM IST
Ranbaxy says US authorities seek information on pricing data
The company said it had received a civil investigative demand (CID) from the US Department of Justice (DOJ) and that it would fully cooperate with the investigation.
Sep 17, 2014, 18:23 PM IST
Sun-Ranbaxy deal: CCI raises concerns about molecules market
Sun Pharma and Ranbaxy had announced a USD 4-billion deal that would create one of the top five largest speciality generics company in the world.
Aug 29, 2014, 13:51 PM IST
Sun Pharma-Ranbaxy deal comes under CCI scanner
CCI would take a final view on the deal after receiving details from them and could seek more information if it is not satisfied with the responses.
Aug 08, 2014, 12:34 PM IST
Sun Pharma to seek shareholders nod for Ranbaxy acquisition
In a filing to the BSE, the company said the meeting would be held at Vadodara on August 22, 2014.
Jul 30, 2014, 19:06 PM IST
Ranbaxy Q1 net loss narrows to Rs 185.92 cr
The company had posted a net loss of Rs 524.24 crore for the corresponding period of the previous fiscal, Ranbaxy Laboratories said in a statement.
Jul 29, 2014, 17:59 PM IST
Management rejig at Ranbaxy; Arno Gessner replaces Dale Adkisson
Meanwhile the company has made Alexander Gebauer as its new head of global research and development.
Jul 26, 2014, 11:16 AM IST
Ranbaxy inks pact with Cipher to sell acne drug in Brazil
Drug major Ranbaxy today said it has inked a licensing pact with Canada's Cipher Pharmaceuticals Inc to exclusively market its isotretinoin capsules, used to treat acne, in Brazil.
Jul 24, 2014, 23:17 PM IST
Sun Pharma-Ranbaxy deal gets BSE, NSE clearance
The combination of Sun Pharma and Ranbaxy creates the fifth-largest speciality generics company in the world and the largest pharmaceutical company in India.
Jul 21, 2014, 13:33 PM IST
